Lv4
460 积分 2026-01-18 加入
Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo
10小时前
待确认
Platinum(IV) Prodrug with a Docosahexaenoic Acid Ligand Preferentially Accumulates in Drug-Resistant Cells and Triggers Ferroptosis to Overcome Drug Resistance
4个月前
已完结
Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
4个月前
已完结
皖公网安备34019202002308
